| HaB Korea.net



COVID-19 treatment
Celltrion Inc., a leading pharmaceutical firm in South Korea, said Friday that its coronavirus antibody treatment substance has shown treatment efficacy in clinical trials. CT-P59 has been administered to 32 healthy volunteers who have not contracted COVID-19 since July after receiving approval for phase one trials from the Ministry of Food and Drug Safety. It...
Read More
South Korea plans to mass-produce an antibody-based therapy for COVID-19 later this month, health authorities said Tuesday. The Ministry of Food and Drug Safety is currently reviewing plans for Phase 2 and Phase 3 clinical trials of the antibody-based treatment, and a large quantity of commercial coronavirus antibodies will be produced this month, said Kwon...
Read More
The U.S. Food and Drug Administration(FDA) has reportedly authorized the use of blood plasma from patients who have recovered from COVID-19 as a treatment for the illness. According to Reuters, the FDA said on Saturday that early evidence suggests blood plasma can decrease mortality and improve the health of patients when administered in the first...
Read More
Oxford University in the United Kingdom is currently developing the COVID-19 vaccine, and it turns out that antibodies have been created to protect the virus from all those vaccinated. Inject the COVID-19 gene into a virus that acts as a harmless carrier for the human body. When the virus comes into contact with fibrous tissue...
Read More
Send this to a friend